Detalhe da pesquisa
1.
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
Blood
; 142(10): 878-886, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319435
2.
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Blood
; 137(5): 600-609, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538797
3.
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.
Am J Hematol
; 98(3): 449-463, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594167
4.
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.
Blood
; 136(5): 572-584, 2020 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32160292
5.
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study.
Lancet Oncol
; 22(4): 512-524, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721562
6.
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.
Blood
; 134(14): 1144-1153, 2019 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409671
7.
Do Mountain Bikers Know When They Have Had a Concussion and, Do They Know to Stop Riding?
Clin J Sport Med
; 31(6): e414-e419, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31895715
8.
Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements.
Blood
; 129(3): 280-288, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821509
9.
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.
Blood
; 127(18): 2182-8, 2016 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26834242
10.
Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.
Lab Invest
; 97(7): 772-781, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28436953
11.
Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy.
N Engl J Med
; 380(24): 2375-2376, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189042
12.
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.
Nature
; 471(7338): 377-81, 2011 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21368758
13.
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.
Nature
; 476(7360): 298-303, 2011 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21796119
14.
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.
PLoS Med
; 13(12): e1002197, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959929
15.
Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma.
Clin Chem
; 62(9): 1238-47, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27440511
16.
Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.
Blood
; 123(11): 1699-708, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24385541
17.
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
Nature
; 463(7277): 88-92, 2010 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20054396
18.
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.
Blood
; 122(7): 1256-65, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23699601
19.
A single-armed proof-of-concept study of Lymfit: A personalized, virtual exercise intervention to improve health outcomes in lymphoma survivors in the pandemic.
PLoS One
; 19(1): e0275038, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180976
20.
Tunable PhenoCycler imaging of the murine pre-clinical tumour microenvironments.
Cell Biosci
; 14(1): 19, 2024 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311785